Spyridon Papapetropoulos is Chief Medical Officer of Vigil Neuroscience Inc.
Person profile
Roles
Vigil Neuroscience
Chief Medical Officer
Lipocine
Director
Address
Emeryville, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Lipocine Inc.
12 May 23
4
Lipocine Inc.
28 Nov 22
4
Vigil Neuroscience, Inc.
22 Nov 22
4
Lipocine Inc.
10 Jun 22
4
Vigil Neuroscience, Inc.
4 May 22
4
Lipocine Inc.
12 Apr 22
3
Lipocine Inc.
12 Apr 22
4
Vigil Neuroscience, Inc.
3 Mar 22
3
Vigil Neuroscience, Inc.
6 Jan 22
4
Adamas Pharmaceuticals Inc
24 Nov 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 May 23 | LPCN Lipocine | Stock Option Common Stock | Grant | Acquire A | No | No | 0.2656 | 30,000 | 7.97 k | 62,000 |
22 Nov 22 | LPCN Lipocine | Common stock | Buy | Acquire P | No | No | 0.47 | 21,739 | 10.22 k | 21,739 |
18 Nov 22 | VIGL Vigil Neuroscience | Common Stock | Sell | Dispose S | No | Yes | 14 | 300 | 4.20 k | 4,000 |
18 Nov 22 | VIGL Vigil Neuroscience | Common Stock | Option exercise | Acquire M | No | No | 1.89 | 300 | 567.00 | 4,300 |
18 Nov 22 | VIGL Vigil Neuroscience | Stock Option Grant Common Stock | Option exercise | Dispose M | No | No | 1.89 | 300 | 567.00 | 149,604 |